Solventum Names Parag Kachalia Global Clinical Evidence Director - Takeaways - DentalSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Solventum Names Parag Kachalia Global Clinical Evidence Director

New role will focus on clinical strategy supporting the company’s digital dental solutions.

  • By

  • News Staff

  • September 28, 2026

Share

  • 1

    Solventum appointed Parag Kachalia, DDS, as global clinical evidence director for its digital dental solutions.

  • 2

    Kachalia joined Solventum on September 15 and will focus on clinical evidence strategy.

  • 3

    He has 25 years of experience in clinical practice, academia, and dental technology strategy.

  • 4

    Kachalia previously served as head of clinical practice at Overjet and chief clinical officer of Seattle Study Club.

  • 5

    He was also a tenured faculty member at the University of the Pacific, Arthur A. Dugoni School of Dentistry.

Original Source(s)

Solventum Names Parag Kachalia Global Clinical Evidence Director

  • by News Staff

  • September 28, 2026

Related Content

Artist Puts Flossing in a New Light

Adam Bock’s interactive artwork FLOSS uses changing light conditions to transform a familiar oral hygiene routine into a visual experience.

Enterovirus diversity may limit treatment advances

Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.

NIH Grant Supports Study of Piezoelectric Technology for Peri-Implantitis

The grant will support evaluation of Oral Biolife’s piezoelectric technology beyond its current development for periodontal bone regeneration.